test-1025-3.pdf
Natiijooyinka Raadinta
Soo bandhiga 1251 - 1260 ee natiijooyinka 4229
Bixiye
QP88-23 MCG Care Guidelines Transparency Tool Available via Availity Essentials by October 27, 2023
Taariikhda uu dhaqangalayo barnaamijka: Okt 25, 2023
Dukaamaysiga & Barashada
2023-dhs-website-summary-v.1.pdf
Bixiye
QP55R1-23 Change in Processing for Replacement Claims
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2023
Bixiye
QP80-23 Blue Cross Response to Medical Oncology Drug Shortage of Cisplatin and Carboplatin
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2023
Bixiye
QP81-23 Update: Medical Drug Update for Tofersen (Qalsody), Delandistrogene Moxeparvovec (Elevidys), and Donislecel (Lantidra)
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2023
Bixiye
QP82-23 Commercial Pharmacy Benefit Exclusion for Beyfortus™, Daxxify®, Izervay™, and Veopoz™
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2023
Bixiye
QP83-23 Commercial Pharmacy Benefit Exclusion for Budesonide-Formoterol Aerosol Inhaler and Tiotropium Bromide Inhalation Capsule
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2023